Coronary Stents Market, By Product Type (Bare-metal Stents, Drug Eluting Stents, and Bioabsorbable Stents), By Material (Metallic (Stainless Steel, Silicon Carbide, Titanium Nitride Oxide, Cobalt Chromium, Platinum Chromium, and Others) and Polymeric (Non

Coronary Stents Market, By Product Type (Bare-metal Stents, Drug Eluting Stents, and Bioabsorbable Stents), By Material (Metallic (Stainless Steel, Silicon Carbide, Titanium Nitride Oxide, Cobalt Chromium, Platinum Chromium, and Others) and Polymeric (Non-degradable/Permanent Stents and Degradable/Temporary Stents)), By End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Coronary stents are small interventional devices used for opening blocked arteries and preventing re-narrowing of arteries. The global coronary stents market report provide a valuable tool for evaluation of coronary stents in the current scenario and trends during the forecast period (2020-2027). The report delivers in depth analysis of factors driving as well as restraining the market growth and also enlightens further market opportunity for manufacturers. The report also covers key developments and company strategies to expand the market share.
Market Dynamics
Product launches coupled with increasing geographical expansion of drug-eluting coronary stents product portfolio is propelling growth of the coronary stents market over the forecast period. For instance, in May 2018, Abbott received the U.S. FDA approval for XIENCE Sierra, the new generation of everolimus-eluting coronary stent. The XIENCE received approval from Japan’s regulatory body in April 2018, and CE mark from European regulatory bodies in 2017. Furthermore, companies are also evaluating and launching products using novel material, such as metal like cobalt chromium and fully biodegradable stents. For instance, in 2017, Biotronik received U.S. Food and Drug Administration approval for PRO-Kinetic energy cobalt chromium-based bare metal coronary stent system to treat coronary artery blockage. However, the coronary stents market growth is subject to stringent regulatory approval policies for interventional devices and medical complications such as restenosis and thrombosis, which is expected to restrain the market growth.
Key features of the study:
This report provides in-depth analysis of the global coronary stents market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global coronary stents market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study are Boston Scientific Corporation, Abbott, Medtronic plc, B. Braun Melsungen AG, Stentsy SA, Terumo Interventional Systems, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc. and Arterial Remodeling Technologies SA
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, type up-gradation, market expansion, and marketing tactics
The global coronary stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global coronary stents market.
Detailed Segmentation:
Global Coronary Stents Market, By Product Type:
Bare-Metal Stents
Drug Eluting Stents
Bioabsorbable Stents
Global Coronary Stents Market, By Material:
Metallic
Stainless Steel
Silicon Carbide
Titanium Nitride Oxide
Cobalt Chromium
Platinum Chromium
Others
Polymeric
Non-degradable/Permanent Stents
Degradable/Temporary Stents
Global Coronary Stents Market, By End User:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Global Coronary Stents Market, By Region:
North America
By Product Type:
Bare-Metal Stents
Drug Eluting Stents
Bioabsorbable Stents
By Material:
Metallic
Stainless Steel
Silicon Carbide
Titanium Nitride Oxide
Cobalt Chromium
Platinum Chromium
Others
Polymeric
Non-degradable/Permanent Stents
Degradable/Temporary Stents
By End User:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Country:
U.S.
Canada
Latin America
By Product Type:
Bare-Metal Stents
Drug Eluting Stents
Bioabsorbable Stents
By Material:
Metallic
Stainless Steel
Silicon Carbide
Titanium Nitride Oxide
Cobalt Chromium
Platinum Chromium
Others
Polymeric
Non-degradable/Permanent Stents
Degradable/Temporary Stents
By End User:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Bare-Metal Stents
Drug Eluting Stents
Bioabsorbable Stents
By Material:
Metallic
Stainless Steel
Silicon Carbide
Titanium Nitride Oxide
Cobalt Chromium
Platinum Chromium
Others
Polymeric
Non-degradable/Permanent Stents
Degradable/Temporary Stents
By End User:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Bare-Metal Stents
Drug Eluting Stents
Bioabsorbable Stents
By Material:
Metallic
Stainless Steel
Silicon Carbide
Titanium Nitride Oxide
Cobalt Chromium
Platinum Chromium
Others
Polymeric
Non-degradable/Permanent Stents
Degradable/Temporary Stents
By End User:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Bare-Metal Stents
Drug Eluting Stents
Bioabsorbable Stents
By Material:
Metallic
Stainless Steel
Silicon Carbide
Titanium Nitride Oxide
Cobalt Chromium
Platinum Chromium
Others
Polymeric
Non-degradable/Permanent Stents
Degradable/Temporary Stents
By End User:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Bare-Metal Stents
Drug Eluting Stents
Bioabsorbable Stents
By Material:
Metallic
Stainless Steel
Silicon Carbide
Titanium Nitride Oxide
Cobalt Chromium
Platinum Chromium
Others
Polymeric
Non-degradable/Permanent Stents
Degradable/Temporary Stents
By End User:
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Boston Scientific Corporation*
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
Abbott
Medtronic Plc
Braun Melsungen AG
Stentsy SA
Terumo Interventional Systems
Kyoto Medical Planning Co., Ltd.
QualiMed
Elixir Medical Corporation
ENDOCOR GmbH
BIOTRONIK SE & Co. KG
Amaranth Medical, Inc.
Arterial Remodeling Technologies SA
“*” marked represents similar segmentation in other categories in the respective section.